Articles tagged "Liver cirrhosis"

2019 American Transplant Congress
Chronic Kidney Disease among Liver Transplant Candidates: A Rising Burden and Its Impact on Post-Liver Transplant Outcomes
G. Cullaro¹, E. C. Verna², B. P. Lee¹, J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY
*Purpose: Chronic kidney disease (CKD) is the end manifestation of persistent renal damage, a pathology distinct from the reversible acute kidney injury (AKI). This distinction…
2019 American Transplant Congress
The Medical Intensive Liver Unit: A Novel Multi-disciplinary Program For The Intensive Care Of Patients With Advanced Liver Disease
C. C. Lindenmeyer¹, G. Flocco¹, A. Sobotka¹, L. Kokoczka², B. Dolan², C. Strauser², C. Romero-Marrero¹, E. Mireles-Cabodevila², H. Khouli², C. Quintini³, A. Kapoor²
¹Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH, ²Department of Critical Care Medicine, Cleveland Clinic, Cleveland, OH, ³Transplantation Center, Cleveland Clinic, Cleveland, OH
*Purpose: Patients with advanced liver disease, particularly those with acute decompensation or acute liver failure (ALF) requiring intensive care unit (ICU) admission, are at elevated…
2019 American Transplant Congress
TIPS Effectively Treats Refractory Hepatic Hydrothorax: A Multi-Center U.S. Retrospective Study of 1,260 Patients
M. German¹, A. Lee¹, A. Hristov¹, A. Said¹, J. Boike², J. Ge³, N. Jest⁴, G. Morelli⁴, K. Kolli³, J. Lai³, A. Desai⁵, S. Junna⁶, B. Pokhrel⁶, T. Couri⁷, S. Paul⁷, C. Frenette⁸, N. Christian-Miller⁸, E. Verna⁹, U. Rahim¹⁰, A. Goel¹⁰, A. Das², S. Pine², D. Gregory², L. VanWagner², E. Spengler¹
¹University of Wisconsin, Madison, WI, ²Northwestern University, Chicago, IL, ³University of California, San Francisco, San Francisco, CA, ⁴University of Florida, Gainesville, FL, ⁵University of Indiana, Indianapolis, IN, ⁶University of Arizona, Tucson, AZ, ⁷University of Chicago, Chicago, IL, ⁸Scripps Clinic, San Diego, CA, ⁹Columbia University, New York, NY, ¹⁰Stanford University, Palo Alto, CA
*Purpose: Hepatic hydrothorax (HHT) occurs in 5-10% of patients with cirrhosis. Current literature on the use of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment…
2019 American Transplant Congress
Hepatocellular Carcinoma in Fontan Liver Disease
V. Lamm¹, J. Wedd², C. Haydek², C. Obineme², A. Noll², H. Veeramachaneni², M. Muftah², R. Ford²
¹Internal Medicine, Emory, Atlanta, GA, ²Emory, Atlanta, GA
*Purpose: To add to the clinical characteristics and outcomes of hepatocellular carcinoma (HCC) in post Fontan operation patients and present, to the best of our…
2019 American Transplant Congress
Early Renal Allograft Failure after Simultaneous Liver-Kidney Transplantation: Evidence for Utilization of the Safety Net
G. Cullaro¹, E. C. Verna², B. J. Orandi³, J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY, ³University of Alabama at Birmingham, Birmingham, AL
*Purpose: Utilization of simultaneous liver-kidney transplant (SLKT) has increased dramatically during the Model for End-Stage Liver Disease (MELD) era. Prior studies have demonstrated a modest…
2019 American Transplant Congress
ALcohol Relapse after Liver Transplantation
B. Movahedi, p. Mahboub, P. Martings, A. Bozorgzadeh
Surgery, UMass Memorial Medical Center, Worcester, MA
*Purpose: Alcoholic liver disease is a very common diagnosis among the patient’s population referred for liver transplantation. There are a number of different evaluation criteria…
2019 American Transplant Congress
Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the Model for End-Stage Liver Disease-Sodium Period
H. Mouzaihem, M. Safwan, L. C. Chau, D. Moonka, M. Abouljoud, S. Nagai
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: While we reported that implementation of MELD-Na based liver allocation improved waitlist outcomes in patients with hyponatremia, its impact on post-transplant outcomes in this…
2019 American Transplant Congress
Targeting Syk Signaling in Myeloid Cells Protects against Liver Fibrosis and Hepatocarcinogenesis
A. Torres-Hernandez, W. Wang, G. Miller
Surgery, NYU School of Medicine, New York, NY
*Purpose: The purpose of our study was to evaluate the mechanistic role of Spleen Tyrosine Kinase (SYK) signaling on the fibrosis - hepatocarcinogenesis axis and…
2019 American Transplant Congress
The Effect of Lifestyle Intervention on Physical Functionality, Progress of Liver Disease and Mortality in Decompensated Cirrhosis Patients in a Community Model
S. Habib, F. Alsafar
Liver Institute PLLC, Tucson, AZ
*Purpose: The study was designed to look at relationships between diet and exercise interventions and liver disease prognosis in terms of survival and ability to…
2019 American Transplant Congress
Statin Underutilization in Patients Listed for Liver Transplant
K. Mishra¹, S. Naffouj¹, S. Modi¹, C. Dagher¹, S. Gorgis¹, D. Venkat²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Transplant Hepatology, Henry Ford Hospital, Detroit, MI
*Purpose: Current guidelines recommend statin use in high risk patients based on the ASCVD (atherosclerotic cardiovascular disease) score, diabetes, or LDL levels. Despite several trials…

« Previous Page
1
…
6
7
8
9
10
…
14
Next Page »